Delivery Order SPE2DB22D1103-SPE2DB25FH1K7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate Extended-Release 36 mg tablets in quantities of 100 units. This contract, valued at $1,697.25, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order was...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,998.07 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 100 packages of 36 mg methylphenidate extended-release tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp, serving as the primary contract vehicle for the company to provide...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.04 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,448.52 to supply Methylphenidate ER 36 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,121.70 to AmerisourceBergen Drug Corp for the supply of Methylphenidate Extended Release 27 mg tablets in a quantity of 100 units. This is a firm fixed price delivery order with no set-aside designation, executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 36 mg, with a ceiling value of $1,366.06. This competitively awarded, firm fixed-price contract was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a relatively small-value transaction typical of routine pharmaceutical procurement within...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,071.23 for Methylphenidate ER 36 mg tablets (100 count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a firm fixed price of $1,260.63. This non-set-aside, competitively awarded contract is classified as a delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and is a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count packages) with a contract value of $2,196.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH1K7Delivery Order
The Defense Logistics Agency awarded a $1,645.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate Extended Release 36 mg. The contract, awarded September 2, 2025, with completion targeted for September 3, 2025, represents a small-value pharmaceutical supply transaction without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare programs worldwide. This delivery order falls within AmerisourceBergen Drug Corp's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Department of Defense and veteran healthcare systems. The Methylphenidate order represents routine pharmaceutical supply fulfillment through the company's DLA contract vehicle, which encompasses delivery of generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The competitive, non-set-aside award demonstrates AmerisourceBergen's continued qualification to serve federal healthcare procurement needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/2/25 |